SeƱora, Julieta N.
HRN: 01-03-93 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/04/2026
CIPROFLOXACIN 2MG/ML, 100ML IV
05/04/2026
05/11/2026
IV
200mg
Q 12 Hours
UTI
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: